July 17, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Vitrakvi | European Medicines Agency (EMA) Rozlytrek | European Medicines Agency (EMA) Rinvoq | European Medicines Agency (EMA) Erbitux | European Medicines Agency (EMA) Rybrevant | European Medicines Agency (EMA) Saphnelo | European Medicines Agency (EMA) Maviret | European Medicines Agency (EMA) Hympavzi | European Medicines Agency (EMA) Vaxneuvance | European Medicines Agency (EMA) Trodelvy | European Medicines Agency (EMA) Xeljanz | European Medicines Agency (EMA)
